Investor Presentation on Financial Results for the Half Year ended 30th September 2026.

CHEMKART INDIA LIMITED CIN-L51220MH2020PLC338631 403/404 K.L. Accolade, 4th Floor, Above Captain Gym, Nr. R.K. Hospital Santacruz (E), MUMBAI 400055 Email Id: investors@chemkart.com | Customer Care: +91 8828505052 Website: www.chemkart.com 30th October 2026 The Corporate Relations Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400001 Scrip Code: 544442 Dear Sir/Madam, Subject: Investor Presentation – Un-Audited Financial Results for the Half Year ended 30th September 2026. Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation based on the Un- Audited Financial Results for the Half Year ended 30th September 2026 which is also uploaded on our website. Kindly take the same on your record. For Chemkart India limited Mohammad Asim Siddiqui Designation – Chief Financial Officer Enclosed: A/a Chemkart India Ltd Investor Presentation - October 2026 Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Chemkart India Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third-party statements and projections. All Maps used in the presentation are not to scale. All data, information, and maps are provided "as is" without warranty or any representation of accuracy, timeliness or completeness. Investor Presentation – October 2026 2 Company Overview Industry Overview Strategic Overview Half-Yearly Financial Performance Historical Financial Performance Investment Rationale The Foundation of Our Future Mission Vision To drive growth and To be a global leader in excellence in food and end-to-end CDMO health ingredients solutions and trusted through quality sourcing, distribution of food, trusted partnerships, and health, and specialty innovative, sustainable ingredients, delivering solutions that empower quality, trust, innovation, customer success. and sustainable growth across the value chain. Investor Presentation – October 2026 4 Company Snapshot 10+ Certifications: Product Categories ISO 9001:2015 | FSSAI | ETC | Pan-India 150+ Ingredients Distribution Network Revenue: 26.9% 500+ (2 Year CAGR) EBITDA: 17.6% Trusted Clients PAT: 19.6% 30K Sq.Ft ROE: Warehouse (FY26) ROCE: Investor Presentation – October 2026 5 About Chemkart Chemkart India Limited, established in March 2015 and headquartered in Mumbai, is a B2B supplier of high-quality raw ingredients used in the manufacturing of nutritional, sports, and health supplements. The company serves a broad spectrum of manufacturers across India, offering a diverse range of ingredients including amino acids like L-Leucine, L-Isoleucine, L-Valine, and L- Lysine HCL. Since inception, the company has built strong relationships with both customers and suppliers and operates on a scalable distribution model, supported by effective inventory forecasting and supply chain responsiveness. • Incorporated in 2020 as a private company; became Chemkart India Limited in 2024. • B2B supplier of raw ingredients for nutritional, sports, and health supplements. • Processes key amino acids & ingredients like L-Leucine, L-Isoleucine, L-Valine, L- Lysine HCL, and more. • In-house blending & grinding facility ensures product customization and quality control. • Strong customer & supplier relationships built since inception. • Focus on operational efficiency, inventory forecasting, and responsive supply chain management. • Serves manufacturers of finished dietary and wellness supplements across India. • The Company’s business operations are further supported by its subsidiaries: Easy Raw Materials Private Limited and Vinstar Biotech Private Limited. Investor Presentation – October 2026 6 Chemkart’s Present Journey 2025 2023 2022 Listed on the BSE SME • Launched VinstarBiotech as Platform under the 2021 a subsidiary to diversify and Expanded logistics name ChemkartIndia broaden business horizons. 2020 footprint with new Limited. • Established presence in SEZ Established EZRMas a 30,000 sq. ft. with a dedicated sales unit Subsidiaryto tap into warehouse facility in 2015 Transitioned into to scale operations. new market segments & Bhiwandi to ChemkartIndia Private strengthen Chemkart strengthen storage Ltd, evolving from a Chemkartcommenced presence and distribution proprietorship to a private operations as a capabilities. limited company to proprietorship, laying strengthen operations. the foundation for its growth. Investor Presentation – October 2026 7 Vision 2030: Global Biotechnology Leader 2030 2027 • Leadership as India’s #1 CRDMO in 2029 Nutraceuticals & Personal Wellness • Commissioning of EZRM SEZ 2028 • Global footprint with 60% Facility –India’s first nutraceutical- • Full-service CDMO offerings: manufacturing driven revenues focused SEZ hub custom molecules → finished • Scale-up of novel technologies: • Entry into integrated dosage forms • Fully integrated solutions: liposomal, microencapsulation, manufacturing of bioactive ingredients, formulations, nanoemulsion, beadlets molecules regulatory, supply chain • Establish export-driven • Establishment of global offices – manufacturing foundation USA, Europe, Middle East • Establishment of R&D Innovation Center Investor Presentation – October 2026 8 Transitioning Into Manufacturing Chemkart India Limited (CIL) announced the commencement of full-scale construction of a greenfield facility at its wholly owned subsidiary, Easy Raw Materials Pvt. Ltd. (EZRM), located in the JNPT Special Economic Zone (SEZ), Maharashtra. This next-generation nutraceutical CDMO facili [Showing first 8,000 characters — download PDF for full document]